Related Experiment Video
Updated: Mar 7, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
A tutorial on the use of instrumental variables in pharmacoepidemiology
Ashkan Ertefaie1,2,3, Dylan S Small2, James H Flory4
1Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
Purpose:
Instrumental variable (IV) methods are used increasingly in pharmacoepidemiology to address unmeasured confounding. In this tutorial, we review the steps used in IV analyses and the underlying assumptions. We also present methods to assess the validity of those assumptions and describe sensitivity analysis to examine the effects of possible violations of those assumptions.
Methods:
Observational studies based on regression or propensity score analyses rely on the untestable assumption that there are no unmeasured confounders. IV analysis is a tool that removes the bias caused by unmeasured confounding provided that key assumptions (some of which are also untestable) are met.
Results:
When instruments are valid, IV methods provided unbiased treatment effect estimation in the presence of unmeasured confounders. However, the standard error of the IV estimate is higher than the standard error of non-IV estimates, e.g., regression and propensity score methods. Sensitivity analyses provided insight about the robustness of the IV results to the plausible degrees of violation of assumptions.
Conclusions:
IV analysis should be used cautiously because the validity of IV estimates relies on assumptions that are, in general, untestable and difficult to be certain about. Thus, assessing the sensitivity of the estimate to violations of these assumptions is important and can better inform the causal inferences that can be drawn from the study. Copyright © 2017 John Wiley & Sons, Ltd.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Analysis of Population Pharmacokinetic Data
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Overview
Pharmacokinetic–Pharmacodynamic Relationship: Model Components